David Raphael Elmaleh, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cromolyn Sodium | 8 | 2023 | 77 | 2.900 |
Why?
|
| Microglia | 6 | 2023 | 1351 | 1.040 |
Why?
|
| Fibroins | 1 | 2024 | 57 | 0.900 |
Why?
|
| Calcium Phosphates | 1 | 2024 | 171 | 0.850 |
Why?
|
| Chitosan | 1 | 2024 | 131 | 0.830 |
Why?
|
| Carbon Radioisotopes | 20 | 2003 | 557 | 0.670 |
Why?
|
| Ibuprofen | 2 | 2018 | 229 | 0.660 |
Why?
|
| Tomography, Emission-Computed | 39 | 2003 | 1121 | 0.650 |
Why?
|
| Tissue Scaffolds | 1 | 2024 | 928 | 0.570 |
Why?
|
| Phagocytosis | 3 | 2021 | 1535 | 0.570 |
Why?
|
| Biocompatible Materials | 1 | 2024 | 1689 | 0.510 |
Why?
|
| Dinucleoside Phosphates | 3 | 2006 | 73 | 0.480 |
Why?
|
| Fatty Acids | 21 | 2005 | 1804 | 0.430 |
Why?
|
| Iodine Radioisotopes | 18 | 1998 | 1032 | 0.420 |
Why?
|
| Alzheimer Disease | 9 | 2023 | 8547 | 0.420 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 1084 | 0.380 |
Why?
|
| Fluorine Radioisotopes | 8 | 2014 | 413 | 0.370 |
Why?
|
| Cocaine | 15 | 2006 | 961 | 0.360 |
Why?
|
| Cytokines | 4 | 2021 | 7343 | 0.360 |
Why?
|
| Heart | 24 | 2011 | 4393 | 0.340 |
Why?
|
| Organophosphorus Compounds | 4 | 2014 | 202 | 0.310 |
Why?
|
| Amyloid beta-Peptides | 8 | 2023 | 3832 | 0.290 |
Why?
|
| Tissue Distribution | 33 | 2011 | 2262 | 0.290 |
Why?
|
| Membrane Transport Proteins | 9 | 2002 | 1035 | 0.280 |
Why?
|
| Neuroprotective Agents | 4 | 2021 | 961 | 0.260 |
Why?
|
| Antithrombin III | 1 | 2005 | 129 | 0.250 |
Why?
|
| Radionuclide Imaging | 22 | 1998 | 1975 | 0.230 |
Why?
|
| Isotope Labeling | 10 | 2003 | 392 | 0.230 |
Why?
|
| Inflammation | 3 | 2023 | 10756 | 0.220 |
Why?
|
| Porosity | 1 | 2024 | 349 | 0.220 |
Why?
|
| Membrane Glycoproteins | 9 | 2002 | 3707 | 0.210 |
Why?
|
| Myocardium | 22 | 2012 | 4700 | 0.210 |
Why?
|
| Phentermine | 4 | 1993 | 31 | 0.200 |
Why?
|
| Positron-Emission Tomography | 6 | 2014 | 6465 | 0.200 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2014 | 296 | 0.200 |
Why?
|
| Dopamine | 9 | 1999 | 1595 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 9 | 2002 | 4407 | 0.190 |
Why?
|
| Brain | 25 | 2021 | 26951 | 0.190 |
Why?
|
| Peptide Fragments | 5 | 2021 | 5125 | 0.180 |
Why?
|
| Cell Line | 7 | 2021 | 15620 | 0.170 |
Why?
|
| Animals | 83 | 2024 | 167963 | 0.170 |
Why?
|
| Carrier Proteins | 9 | 2001 | 4938 | 0.170 |
Why?
|
| Rats | 38 | 2011 | 23711 | 0.160 |
Why?
|
| Half-Life | 5 | 2017 | 652 | 0.160 |
Why?
|
| Myristic Acids | 4 | 1988 | 49 | 0.160 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 10 | 2006 | 415 | 0.160 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 6 | 1998 | 1067 | 0.150 |
Why?
|
| Dogs | 24 | 1995 | 3841 | 0.140 |
Why?
|
| Chemokines | 1 | 2021 | 962 | 0.140 |
Why?
|
| Receptors, Dopamine D1 | 4 | 1998 | 293 | 0.140 |
Why?
|
| Receptors, Dopamine | 3 | 2002 | 292 | 0.130 |
Why?
|
| Parkinson Disease, Secondary | 5 | 1998 | 122 | 0.130 |
Why?
|
| Chlorphentermine | 2 | 1993 | 2 | 0.130 |
Why?
|
| Onium Compounds | 2 | 2012 | 27 | 0.130 |
Why?
|
| Technetium | 6 | 1998 | 321 | 0.130 |
Why?
|
| Crown Ethers | 1 | 2014 | 4 | 0.120 |
Why?
|
| Brain Chemistry | 5 | 1998 | 959 | 0.120 |
Why?
|
| Thallium Radioisotopes | 3 | 1991 | 138 | 0.120 |
Why?
|
| Radioimmunodetection | 1 | 1994 | 45 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1791 | 0.120 |
Why?
|
| Fibrosis | 1 | 2021 | 2042 | 0.120 |
Why?
|
| Rabbits | 9 | 2011 | 4773 | 0.110 |
Why?
|
| Radioisotopes | 11 | 1986 | 495 | 0.110 |
Why?
|
| Phosphines | 2 | 2011 | 18 | 0.110 |
Why?
|
| Biotin | 1 | 1994 | 253 | 0.110 |
Why?
|
| Mitochondria, Heart | 2 | 2012 | 229 | 0.110 |
Why?
|
| Arteriosclerosis | 1 | 1998 | 1064 | 0.110 |
Why?
|
| Parkinson Disease | 6 | 2008 | 2859 | 0.110 |
Why?
|
| Iodobenzenes | 4 | 1994 | 23 | 0.110 |
Why?
|
| Benzoates | 1 | 1994 | 212 | 0.110 |
Why?
|
| Coronary Circulation | 5 | 2012 | 1577 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1741 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2005 | 3061 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 10827 | 0.100 |
Why?
|
| Fluorobenzenes | 1 | 1994 | 180 | 0.100 |
Why?
|
| Deoxyglucose | 10 | 1994 | 333 | 0.100 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2018 | 1110 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 1881 | 0.100 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 2 | 2002 | 36 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2021 | 2864 | 0.100 |
Why?
|
| Organotechnetium Compounds | 3 | 1994 | 129 | 0.100 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 2061 | 0.100 |
Why?
|
| Dopamine Uptake Inhibitors | 3 | 1999 | 297 | 0.100 |
Why?
|
| Proteome | 1 | 2021 | 1855 | 0.100 |
Why?
|
| Piperazines | 4 | 2000 | 2525 | 0.090 |
Why?
|
| Autoradiography | 6 | 1998 | 730 | 0.090 |
Why?
|
| Mannose-Binding Lectin | 1 | 2012 | 146 | 0.090 |
Why?
|
| Escherichia coli Infections | 1 | 1994 | 523 | 0.090 |
Why?
|
| Biogenic Monoamines | 2 | 2001 | 50 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2006 | 3517 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 1796 | 0.090 |
Why?
|
| Putamen | 4 | 1998 | 291 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2017 | 4035 | 0.080 |
Why?
|
| Computational Biology | 1 | 2021 | 3505 | 0.080 |
Why?
|
| Rats, Inbred Strains | 10 | 1992 | 2094 | 0.080 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2019 | 1463 | 0.080 |
Why?
|
| Tellurium | 3 | 1985 | 21 | 0.080 |
Why?
|
| Fluorine | 6 | 1984 | 83 | 0.080 |
Why?
|
| Oxygen Radioisotopes | 2 | 1986 | 75 | 0.070 |
Why?
|
| Caudate Nucleus | 3 | 1994 | 389 | 0.070 |
Why?
|
| Drug Approval | 1 | 2014 | 816 | 0.070 |
Why?
|
| Radiopharmaceuticals | 3 | 2012 | 2634 | 0.070 |
Why?
|
| Rats, Inbred F344 | 5 | 1994 | 825 | 0.070 |
Why?
|
| Humans | 37 | 2024 | 760621 | 0.070 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2012 | 571 | 0.070 |
Why?
|
| Palmitic Acids | 2 | 1983 | 52 | 0.070 |
Why?
|
| Lewy Body Disease | 1 | 2008 | 252 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9411 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2023 | 2488 | 0.060 |
Why?
|
| Ligands | 8 | 2014 | 3276 | 0.060 |
Why?
|
| Affinity Labels | 1 | 1985 | 107 | 0.060 |
Why?
|
| Soft Tissue Neoplasms | 5 | 1991 | 1152 | 0.060 |
Why?
|
| Glucose | 9 | 1994 | 4351 | 0.060 |
Why?
|
| Gallium Radioisotopes | 3 | 1983 | 195 | 0.060 |
Why?
|
| Azides | 1 | 1985 | 118 | 0.060 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 6 | 1998 | 90 | 0.060 |
Why?
|
| Molecular Structure | 2 | 2006 | 1895 | 0.060 |
Why?
|
| Adenine Nucleotides | 1 | 1984 | 111 | 0.060 |
Why?
|
| Macaca fascicularis | 7 | 2006 | 900 | 0.060 |
Why?
|
| Luciferases | 1 | 2005 | 716 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 11903 | 0.060 |
Why?
|
| Ritonavir | 1 | 2005 | 328 | 0.050 |
Why?
|
| Zidovudine | 1 | 2005 | 624 | 0.050 |
Why?
|
| Parkinsonian Disorders | 1 | 2006 | 284 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2011 | 8158 | 0.050 |
Why?
|
| Mice | 20 | 2021 | 81208 | 0.050 |
Why?
|
| Macaca mulatta | 5 | 2021 | 2316 | 0.050 |
Why?
|
| Cognition | 2 | 2019 | 6957 | 0.050 |
Why?
|
| Deoxy Sugars | 4 | 1984 | 20 | 0.050 |
Why?
|
| Carbon Dioxide | 2 | 1984 | 1146 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2021 | 23376 | 0.050 |
Why?
|
| Burns | 1 | 2014 | 1866 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2023 | 151 | 0.050 |
Why?
|
| Thiazoles | 3 | 2014 | 1511 | 0.050 |
Why?
|
| Aging | 1 | 2021 | 8651 | 0.050 |
Why?
|
| Nerve Endings | 3 | 1996 | 105 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 1990 | 1902 | 0.050 |
Why?
|
| Fluconazole | 2 | 1992 | 155 | 0.050 |
Why?
|
| Disease Models, Animal | 7 | 2018 | 18137 | 0.050 |
Why?
|
| Transferrin | 2 | 1979 | 284 | 0.050 |
Why?
|
| Indium | 2 | 1986 | 46 | 0.050 |
Why?
|
| Receptors, Serotonin | 2 | 2002 | 208 | 0.040 |
Why?
|
| Injections, Intravenous | 2 | 2011 | 1385 | 0.040 |
Why?
|
| Cattle | 1 | 2005 | 3847 | 0.040 |
Why?
|
| Male | 32 | 2019 | 359744 | 0.040 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 1999 | 65 | 0.040 |
Why?
|
| Benzamides | 1 | 1985 | 1369 | 0.040 |
Why?
|
| Gallium | 1 | 1979 | 27 | 0.040 |
Why?
|
| Saimiri | 2 | 1998 | 334 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2005 | 1435 | 0.040 |
Why?
|
| Myocardial Reperfusion | 2 | 1991 | 347 | 0.040 |
Why?
|
| Heparin | 1 | 2005 | 1652 | 0.040 |
Why?
|
| Amines | 1 | 1999 | 281 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2023 | 1246 | 0.040 |
Why?
|
| Killer Cells, Natural | 2 | 2005 | 2203 | 0.040 |
Why?
|
| Aged | 8 | 2019 | 169152 | 0.040 |
Why?
|
| Apoptosis | 1 | 2014 | 9501 | 0.040 |
Why?
|
| Virus Replication | 1 | 2005 | 2432 | 0.040 |
Why?
|
| Transfection | 1 | 2005 | 5781 | 0.040 |
Why?
|
| Nortropanes | 1 | 1997 | 12 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 2019 | 406 | 0.040 |
Why?
|
| Citalopram | 2 | 1998 | 402 | 0.030 |
Why?
|
| Serum Albumin | 2 | 1994 | 674 | 0.030 |
Why?
|
| Amides | 1 | 1999 | 448 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2014 | 1347 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 3735 | 0.030 |
Why?
|
| Aniline Compounds | 2 | 2014 | 1069 | 0.030 |
Why?
|
| Serotonin Antagonists | 1 | 1996 | 144 | 0.030 |
Why?
|
| Motor Activity | 5 | 2002 | 2687 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2018 | 232 | 0.030 |
Why?
|
| Middle Aged | 6 | 2019 | 220352 | 0.030 |
Why?
|
| Perfusion | 3 | 2011 | 1376 | 0.030 |
Why?
|
| Myocardial Infarction | 6 | 1991 | 11891 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2003 | 1544 | 0.030 |
Why?
|
| Avidin | 1 | 1994 | 42 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2021 | 18957 | 0.030 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 1995 | 190 | 0.030 |
Why?
|
| Flavonols | 1 | 2014 | 83 | 0.030 |
Why?
|
| Pyridines | 1 | 1986 | 2879 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2019 | 865 | 0.030 |
Why?
|
| Valinomycin | 1 | 2014 | 17 | 0.030 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2014 | 22 | 0.030 |
Why?
|
| Transgenes | 1 | 2018 | 1006 | 0.030 |
Why?
|
| Hemodynamics | 4 | 2012 | 4174 | 0.030 |
Why?
|
| Piperidines | 1 | 2002 | 1650 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 58995 | 0.030 |
Why?
|
| Radioligand Assay | 3 | 2002 | 366 | 0.030 |
Why?
|
| Dementia | 1 | 2008 | 2649 | 0.030 |
Why?
|
| Reward | 1 | 2001 | 963 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 9530 | 0.030 |
Why?
|
| Structure-Activity Relationship | 5 | 2002 | 3084 | 0.030 |
Why?
|
| Kinetics | 7 | 1985 | 6377 | 0.030 |
Why?
|
| Tropanes | 1 | 1993 | 51 | 0.030 |
Why?
|
| Cell Movement | 1 | 2005 | 5206 | 0.030 |
Why?
|
| Chromatography, Thin Layer | 1 | 1993 | 212 | 0.030 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2006 | 485 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 22023 | 0.030 |
Why?
|
| Staurosporine | 1 | 2014 | 242 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 697 | 0.030 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2018 | 565 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2005 | 4353 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 2 | 1986 | 1628 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 10 | 1994 | 2007 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 3 | 1996 | 2733 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2012 | 6659 | 0.020 |
Why?
|
| Coronary Disease | 6 | 1988 | 5990 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2018 | 2025 | 0.020 |
Why?
|
| Brain Tissue Transplantation | 1 | 1992 | 81 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2005 | 4550 | 0.020 |
Why?
|
| Flavonoids | 1 | 2014 | 445 | 0.020 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1992 | 137 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2019 | 1817 | 0.020 |
Why?
|
| Liver | 4 | 1995 | 7509 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1984 | 2299 | 0.020 |
Why?
|
| Female | 19 | 2019 | 391270 | 0.020 |
Why?
|
| Nervous System Neoplasms | 1 | 1991 | 91 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2012 | 433 | 0.020 |
Why?
|
| Ventricular Function, Left | 2 | 1993 | 3880 | 0.020 |
Why?
|
| Methylation | 1 | 1993 | 1082 | 0.020 |
Why?
|
| Glioma | 2 | 1984 | 3420 | 0.020 |
Why?
|
| Potassium | 1 | 2014 | 1313 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1990 | 2558 | 0.020 |
Why?
|
| Contrast Media | 2 | 1997 | 5305 | 0.020 |
Why?
|
| Alcoholic Intoxication | 1 | 1990 | 174 | 0.020 |
Why?
|
| Regional Blood Flow | 4 | 1991 | 1490 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 1990 | 400 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2005 | 4491 | 0.020 |
Why?
|
| Scandium | 3 | 1983 | 7 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 1990 | 532 | 0.020 |
Why?
|
| Candidiasis | 1 | 1991 | 363 | 0.020 |
Why?
|
| Hypertension | 2 | 1986 | 8594 | 0.020 |
Why?
|
| Oximetry | 1 | 2012 | 461 | 0.020 |
Why?
|
| Oxygen Consumption | 2 | 1985 | 1843 | 0.020 |
Why?
|
| Microspheres | 4 | 1988 | 787 | 0.020 |
Why?
|
| Nitrogen Radioisotopes | 2 | 1986 | 41 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 1972 | 0.020 |
Why?
|
| Influenza A virus | 1 | 2012 | 457 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 9185 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 1990 | 6216 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 1992 | 708 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 1377 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2000 | 3765 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 1984 | 4319 | 0.020 |
Why?
|
| HIV-1 | 1 | 2005 | 6849 | 0.020 |
Why?
|
| Thallium | 2 | 1985 | 100 | 0.020 |
Why?
|
| Spleen | 1 | 2014 | 2298 | 0.020 |
Why?
|
| Fasting | 1 | 1994 | 1603 | 0.020 |
Why?
|
| Ethylenediamines | 1 | 1987 | 57 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 2 | 2005 | 361 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1993 | 819 | 0.020 |
Why?
|
| Macaca nemestrina | 1 | 1986 | 21 | 0.020 |
Why?
|
| Angina, Unstable | 1 | 1991 | 926 | 0.020 |
Why?
|
| Doxorubicin | 1 | 1993 | 2209 | 0.020 |
Why?
|
| Biliary Tract | 1 | 1987 | 135 | 0.020 |
Why?
|
| Radiation | 1 | 1986 | 48 | 0.020 |
Why?
|
| Iron Chelating Agents | 1 | 1987 | 138 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1677 | 0.020 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2006 | 107 | 0.020 |
Why?
|
| Insulin | 2 | 1994 | 6597 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2012 | 1016 | 0.020 |
Why?
|
| Photolysis | 1 | 1985 | 94 | 0.020 |
Why?
|
| Gene Expression | 1 | 2018 | 7588 | 0.020 |
Why?
|
| Chemistry | 1 | 1985 | 348 | 0.020 |
Why?
|
| Huntington Disease | 1 | 1992 | 1141 | 0.020 |
Why?
|
| Phenethylamines | 1 | 1985 | 95 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1985 | 508 | 0.020 |
Why?
|
| Lactates | 2 | 1998 | 404 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1990 | 1207 | 0.010 |
Why?
|
| Methylglycosides | 1 | 1983 | 10 | 0.010 |
Why?
|
| Ethanol | 1 | 1990 | 1323 | 0.010 |
Why?
|
| Methylglucosides | 1 | 1983 | 35 | 0.010 |
Why?
|
| 3-O-Methylglucose | 1 | 1983 | 37 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1985 | 461 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2012 | 1462 | 0.010 |
Why?
|
| Arsenicals | 1 | 1984 | 117 | 0.010 |
Why?
|
| Fibroma | 1 | 1985 | 190 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 1996 | 3061 | 0.010 |
Why?
|
| Quinolinic Acid | 2 | 1994 | 67 | 0.010 |
Why?
|
| Apomorphine | 2 | 1994 | 149 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1994 | 2869 | 0.010 |
Why?
|
| Elementary Particles | 2 | 1979 | 52 | 0.010 |
Why?
|
| Hyperkinesis | 1 | 2002 | 89 | 0.010 |
Why?
|
| Liposarcoma | 1 | 1985 | 283 | 0.010 |
Why?
|
| Hippocampus | 1 | 2014 | 3738 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1994 | 3562 | 0.010 |
Why?
|
| Dopamine Antagonists | 1 | 2002 | 288 | 0.010 |
Why?
|
| Neurons | 2 | 2018 | 9426 | 0.010 |
Why?
|
| Models, Biological | 4 | 2012 | 9467 | 0.010 |
Why?
|
| Binding Sites | 3 | 1997 | 6048 | 0.010 |
Why?
|
| Movement | 1 | 2008 | 1474 | 0.010 |
Why?
|
| Quinolines | 1 | 2006 | 759 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2005 | 1955 | 0.010 |
Why?
|
| Sarcoma | 1 | 1991 | 1786 | 0.010 |
Why?
|
| Sodium Fluoride | 1 | 1979 | 62 | 0.010 |
Why?
|
| Extremities | 1 | 1985 | 867 | 0.010 |
Why?
|
| Carboxyhemoglobin | 1 | 1979 | 80 | 0.010 |
Why?
|
| Cocaine-Related Disorders | 1 | 2002 | 460 | 0.010 |
Why?
|
| Conditioning, Operant | 1 | 2001 | 308 | 0.010 |
Why?
|
| Fluorides | 1 | 1979 | 134 | 0.010 |
Why?
|
| Muscles | 1 | 1984 | 1581 | 0.010 |
Why?
|
| Calcium | 1 | 2012 | 5725 | 0.010 |
Why?
|
| Iron | 1 | 1987 | 1786 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1979 | 282 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 1985 | 1019 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 1983 | 978 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 1990 | 4013 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1984 | 1993 | 0.010 |
Why?
|
| Time Factors | 4 | 2011 | 40165 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16939 | 0.010 |
Why?
|
| Macrophages | 1 | 2012 | 5745 | 0.010 |
Why?
|
| Neostriatum | 1 | 1998 | 246 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1999 | 1763 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14372 | 0.010 |
Why?
|
| Gold Radioisotopes | 2 | 1986 | 3 | 0.010 |
Why?
|
| Krypton | 2 | 1986 | 21 | 0.010 |
Why?
|
| Xenon Radioisotopes | 2 | 1986 | 33 | 0.010 |
Why?
|
| Protein Binding | 2 | 1998 | 9335 | 0.010 |
Why?
|
| Neoplasms | 1 | 1985 | 22072 | 0.010 |
Why?
|
| Dopamine Agents | 1 | 1997 | 189 | 0.010 |
Why?
|
| Carbon Monoxide | 1 | 1979 | 540 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2001 | 1735 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 7021 | 0.010 |
Why?
|
| Iridium | 2 | 1986 | 95 | 0.010 |
Why?
|
| Skull | 1 | 1980 | 815 | 0.010 |
Why?
|
| Hydrocarbons, Iodinated | 1 | 1994 | 8 | 0.010 |
Why?
|
| Spectrometry, Mass, Fast Atom Bombardment | 1 | 1994 | 32 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 1998 | 748 | 0.010 |
Why?
|
| Pyrimidinones | 1 | 1996 | 384 | 0.010 |
Why?
|
| Gated Blood-Pool Imaging | 1 | 1993 | 42 | 0.010 |
Why?
|
| Acetylcholinesterase | 1 | 1994 | 156 | 0.010 |
Why?
|
| Isotopes | 2 | 1985 | 125 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1993 | 252 | 0.010 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 1993 | 173 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 12965 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1986 | 2809 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1994 | 370 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2001 | 1878 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 1998 | 1233 | 0.010 |
Why?
|
| Ibotenic Acid | 1 | 1992 | 59 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 1980 | 1182 | 0.010 |
Why?
|
| Necrosis | 2 | 1986 | 1612 | 0.010 |
Why?
|
| Drug Stability | 1 | 1991 | 290 | 0.010 |
Why?
|
| Dequalinium | 1 | 1991 | 7 | 0.010 |
Why?
|
| Tumor Stem Cell Assay | 1 | 1991 | 115 | 0.010 |
Why?
|
| Neurotoxins | 1 | 1992 | 240 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1994 | 1351 | 0.010 |
Why?
|
| Neoplasm Transplantation | 2 | 1985 | 2014 | 0.010 |
Why?
|
| Papio | 1 | 1992 | 661 | 0.010 |
Why?
|
| Movement Disorders | 1 | 1994 | 459 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1979 | 2415 | 0.010 |
Why?
|
| Cricetinae | 1 | 1993 | 2427 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1993 | 1850 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 1992 | 549 | 0.010 |
Why?
|
| Acetates | 1 | 1990 | 321 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1980 | 4902 | 0.010 |
Why?
|
| Heart Failure | 1 | 1993 | 11847 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 1988 | 92 | 0.010 |
Why?
|
| Kidney | 1 | 1984 | 7064 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1988 | 660 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1983 | 5761 | 0.000 |
Why?
|
| Rubidium | 1 | 1986 | 122 | 0.000 |
Why?
|
| United States | 1 | 2014 | 72461 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1994 | 36290 | 0.000 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 1985 | 63 | 0.000 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1985 | 67 | 0.000 |
Why?
|
| Behavior, Animal | 1 | 1994 | 1866 | 0.000 |
Why?
|
| Pentetic Acid | 1 | 1985 | 209 | 0.000 |
Why?
|
| Particle Accelerators | 1 | 1986 | 174 | 0.000 |
Why?
|
| Iofetamine | 1 | 1985 | 14 | 0.000 |
Why?
|
| Lactic Acid | 1 | 1990 | 1134 | 0.000 |
Why?
|
| Rats, Inbred SHR | 1 | 1985 | 186 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1986 | 641 | 0.000 |
Why?
|
| Photochemotherapy | 1 | 1991 | 820 | 0.000 |
Why?
|
| Amphetamines | 1 | 1985 | 143 | 0.000 |
Why?
|
| Endocardium | 1 | 1985 | 246 | 0.000 |
Why?
|
| Heart Septum | 1 | 1985 | 303 | 0.000 |
Why?
|
| Transplantation, Heterologous | 1 | 1992 | 2379 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1991 | 6131 | 0.000 |
Why?
|
| Tin | 1 | 1982 | 13 | 0.000 |
Why?
|
| Radiation Dosage | 2 | 1981 | 1958 | 0.000 |
Why?
|
| Graft Survival | 1 | 1992 | 3794 | 0.000 |
Why?
|
| Radioactive Tracers | 1 | 1981 | 66 | 0.000 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1982 | 393 | 0.000 |
Why?
|
| Adult | 4 | 1998 | 219994 | 0.000 |
Why?
|
| Haplorhini | 1 | 1980 | 529 | 0.000 |
Why?
|
| Nuclear Medicine | 1 | 1983 | 236 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1984 | 2502 | 0.000 |
Why?
|
| Blood Volume | 1 | 1980 | 550 | 0.000 |
Why?
|
| Ammonia | 1 | 1979 | 236 | 0.000 |
Why?
|
| Cell Survival | 1 | 1988 | 5797 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1992 | 11071 | 0.000 |
Why?
|
| Blood Glucose | 2 | 1983 | 6381 | 0.000 |
Why?
|
| Lung | 1 | 1995 | 9994 | 0.000 |
Why?
|
| Adolescent | 2 | 1998 | 87810 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1983 | 1273 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1988 | 5961 | 0.000 |
Why?
|
| Neoplasms, Experimental | 1 | 1980 | 1229 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1992 | 20509 | 0.000 |
Why?
|
| Aortic Valve Stenosis | 1 | 1985 | 2065 | 0.000 |
Why?
|
| Prognosis | 1 | 1991 | 29658 | 0.000 |
Why?
|
| Child | 1 | 1998 | 79806 | 0.000 |
Why?
|
| Oxygen | 1 | 1980 | 4193 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1985 | 39261 | 0.000 |
Why?
|